For research use only. Not for therapeutic Use.
(R)-BDP9066 is a potent inhibitor of myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK). (R)-BDP9066 blocks cancer cell invasion. (R)-BDP9066 has the potential for the research of proliferative diseases, such as cancer.
| Catalog Number | I044133 |
| CAS Number | 2284549-25-1 |
| Synonyms | (6R)-8-(3-pyrimidin-4-yl-1H-pyrrolo[2,3-b]pyridin-4-yl)-1,8-diazaspiro[5.5]undecane |
| Molecular Formula | C20H24N6 |
| Purity | ≥95% |
| InChI | InChI=1S/C20H24N6/c1-2-8-25-20(6-1)7-3-11-26(13-20)17-5-10-22-19-18(17)15(12-23-19)16-4-9-21-14-24-16/h4-5,9-10,12,14,25H,1-3,6-8,11,13H2,(H,22,23)/t20-/m1/s1 |
| InChIKey | UELSMLDRSQFVHG-HXUWFJFHSA-N |
| SMILES | C1CCNC2(C1)CCCN(C2)C3=C4C(=CNC4=NC=C3)C5=NC=NC=C5 |
| Reference | [1]. Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer. Patent WO2019034890A1. |
